SNO 2024: Advancing Neuro-Oncology with Multi-Omics Approaches

MetwareBio is excited to participate in the Society for Neuro-Oncology (SNO) Annual Meeting 2024, a leading event dedicated to advancing neuro-oncology research. Our multi-omics platforms, including metabolomics and proteomics, provide critical insights into the molecular mechanisms driving brain tumors, helping researchers identify biomarkers and potential therapeutic targets.

Join us from November 21-24, 2024, in Houston, Texas, to discover how our high-throughput omics technologies can enhance your research in areas such as gliomas, medulloblastomas, and other central nervous system tumors. Visit us at our booth to learn how our services can support your neuro-oncology research, offering precise data and actionable insights.

We invite you to stop by our booth to explore how MetwareBio can partner with you on your next project. Schedule a Meeting today to ensure a one-on-one consultation with our experts during the conference.

Conference Details:

· Date: November 21-24, 2024

· Location: Houston, Texas, USA

· Website: official event website